Article info

Download PDFPDF

An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation

Authors

  1. Correspondence to Professor Frank J Chaloupka, Department of Economics, Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL 60608, USA; fjc{at}uic.edu
View Full Text

Citation

Chaloupka FJ, Warner KE, Acemoğlu D, et al
An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation

Publication history

  • Received October 1, 2014
  • Accepted November 28, 2014
  • First published December 30, 2014.
Online issue publication 
February 20, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.